Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

US military simulation spending to exceed $26 billion annually up to 2028, forecasts GlobalData

The US is poised to significantly bolster its military simulation and training expenditure, surpassing $26 billion annually up to 2028. With a focus on enhancing military readiness and response capabilities, this substantial investment underscores the nation’s commitment to aerospace, defense, and security. The allocation of resources into advanced training systems reflects the evolving geopolitical landscape […]
Read more

UK VC funding investment plunges by 41.3% YoY to $615.4 million in January 2024, finds GlobalData

The UK’s venture capital (VC) landscape experienced a significant year-on-year (YoY) decline of 41.3% to $615.4 million in January 2024. This decline, attributed to macroeconomic challenges and geopolitical tensions, reflects a cautious approach among investors. Despite this setback, the UK remains a prominent player in the global VC market, though facing increased competition from other […]
Read more

Transcatheter tricuspid valve repair market set to grow over $2 billion by 2033, forecasts GlobalData

The transcatheter tricuspid valve replacement (TTVR) system, EVOQUE, by Edwards Lifesciences is a minimally invasive treatment option for tricuspid regurgitation (TR). Since receiving CE approval in October 2023 and FDA approval earlier this month, the EVOQUE TTVR system has become the only transcatheter therapy globally available to treat severe TR. With the approval of the […]
Read more

Defensive AI safeguards against emerging cyber threats, says GlobalData

Google’s recent announcement of an artificial intelligence (AI) Cyber Defense Initiative to enhance global cybersecurity underscores the importance of defending against increasingly sophisticated and pervasive cyber threats. AI is expected to play a pivotal role in collecting, processing, and neutralizing threats, transforming the way organizations combat cyber risks, observes GlobalData, a leading data and analytics […]
Read more

3D bioprinting breakthroughs mark turning point in regenerative medicine, observes GlobalData

3D bioprinting has achieved a landmark breakthrough with researchers at the University of Wisconsin Madison recently developing a novel method for printing functional human brain tissue. Likewise, at the Vienna University of Technology, researchers have advanced in generating replacement tissue for potentially treating injured cartilage through lab-based 3D printing. These developments signify a crucial turning […]
Read more

AI-powered diagnosis apps signify transformative shift in healthcare delivery, says GlobalData

Advancements in medical technology, particularly the integration of artificial intelligence (AI), are reshaping diagnostic procedures and patient care. With the burgeoning market for AI-driven diagnostics expected to surpass $908.7 billion in 2030, innovative AI-powered diagnosis apps signify a transformative shift in healthcare delivery. These technologies promise real-time insights, personalized treatment plans, and cost-effective solutions, enhancing […]
Read more

Capital One $35 billion acquisition of Discover Financial attracts diverse opinions from influencers, finds GlobalData

Warren Buffett-backed global consumer lender Capital One Financial has agreed to acquire American credit card issuer and banking services provider Discover Financial Services (DFS)  for $35 billion. Some influencers are optimistic about the deal, as it would create the largest US credit card lender while others are skeptical, considering the potential regulatory challenges and the […]
Read more

Takeda oncology pipeline remains robust despite shift in focus from CAR-T to allogeneic cell therapies, says GlobalData

Takeda has decided to discontinue the development programs of its four oncology assets—Phase III asset modakafusp alfa (TAK-573) and three Phase I chimeric antigen receptor (CAR-T)  assets: TAK-102, TAK-103 and TAK-940—as part of a plan to align its focus on advancing allogeneic cell therapies. Despite these adjustments, the Japan-based pharma major’s oncology pipeline remains robust, […]
Read more

GlobalData spotlights AMD treatment evolution amid rising prevalence

As February marks age-related macular degeneration (AMD) Awareness Month, the spotlight shines on groundbreaking advancements in AMD treatment. With AMD affecting millions globally, innovative therapies are reshaping the landscape of ophthalmology. Amidst rising prevalence and urgent treatment needs, the evolution in AMD management promises new hope for patients, driven by transformative approaches and research, according […]
Read more

India pharma giants and global big pharma join forces for NMEs commercialization in India, says GlobalData

The pharmaceutical landscape has undergone a significant shift towards collaboration and partnership between global big pharma and Indian pharmaceutical firms in recent years to drive innovation and expand market reach. This strategic alliance brings together the strengths and resources of both parties to accelerate commercialization. The focus is on introducing new molecular entities (NMEs) into […]
Read more

Japan dental implants market to reach $230 million in 2033, forecasts GlobalData

Periodontal disease remains a prevalent concern in Japan, alongside other dental conditions. Even though dental implants offer a reliable and effective solution for replacing teeth lost to periodontal disease, addressing these illnesses comprehensively presents various challenges, including barriers to dental care access. Against this backdrop, the dental implants market in Japan is set to reach […]
Read more

International Gaucher Alliance reveals five-year plan to empower patients worldwide, says GlobalData

The International Gaucher Alliance (IGA) marks its 30th anniversary with a five-year strategic plan to advocate for Gaucher patients globally. The plan underscores a commitment to advocacy and collaboration, aiming to drive tangible advancements in patient access, research, and community empowerment, according to GlobalData, a leading data and analytics company. Gaucher disease, which is caused […]
Read more

Alirocumab can address unmet needs in pediatric familial hypercholesterolemia, says GlobalData

Heterozygous familial hypercholesterolemia (HeFH) is an autosomal dominant disorder characterized by elevated levels of low-density lipoprotein cholesterol (LDL-C), leading to an increased risk of cardiovascular disease. Praluent (alirocumab) is a monoclonal antibody against proprotein convertase subtilisin kexin type 9 (PCSK9), an enzyme that promotes degradation of the low-density lipoprotein (LDL) receptor, which is responsible for […]
Read more

India and AI trend in companies discussions in 2023, reveals GlobalData Company Filings Analytics report

Industrials and consumer industries business sentiment improves India, Italy, Mexico, Saudi Arabia, and Ukraine trend with improved sentiment Supply chain, AI, inflation, and metaverse garner higher mentions Amidst market dynamics in 2023, global business sentiment witnessed a dip compared to the preceding year.  India and artificial intelligence (AI) were widely discussed by companies during the […]
Read more

Top 20 global biopharmaceutical companies report 1.6% market capitalization growth to $3.67 trillion in 2023, reveals GlobalData

The top 20 global biopharmaceutical companies experienced varied year-on-year (YoY) market capitalization shifts in 2023 amid the macroeconomic headwinds, steep patent cliffs and the commencement of US drug price negotiations under the Inflation Reduction Act (IRA). Nonetheless, there was a resilient upturn of 1.6% in aggregate market capitalization from $3.61 trillion on 31 December 2022 […]
Read more
1 … 74 75 76 77 78 … 209